• The Americas is set to be the leading region for the hepatitis drugs market growth followed by Europe.
• Japan is set to be the most attractive destination and in Africa, the popularity and the usage of various HBV and HCV drugs are expected to increase in the coming years.
• The Asia Pacific and RoW are set to be the emerging regions
Regions
• The Americas is set to be the leading region for the hepatitis drugs market growth followed by Europe.
• Japan is set to be the most attractive destination and in Africa, the popularity and the usage of various HBV and HCV drugs are expected to increase in the coming years.
• The Asia Pacific and RoW are set to be the emerging regions